Cargando…

5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity

RIG-I is a cytosolic receptor for non-self RNA that mediates immune responses against viral infections through IFNα/β production. In an attempt to identify novel tools that modulate IFNα/β production, we used SELEX technology to screen RNA aptamers that specifically target RIG-I protein. Most of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Sun-Young, Sun, Hwa-Young, Lee, Kwang-Hoon, Oh, Byung-Ha, Cha, Yu Jin, Kim, Byeang Hyean, Yoo, Joo-Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
RNA
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315321/
https://www.ncbi.nlm.nih.gov/pubmed/22127865
http://dx.doi.org/10.1093/nar/gkr1098
_version_ 1782228214355066880
author Hwang, Sun-Young
Sun, Hwa-Young
Lee, Kwang-Hoon
Oh, Byung-Ha
Cha, Yu Jin
Kim, Byeang Hyean
Yoo, Joo-Yeon
author_facet Hwang, Sun-Young
Sun, Hwa-Young
Lee, Kwang-Hoon
Oh, Byung-Ha
Cha, Yu Jin
Kim, Byeang Hyean
Yoo, Joo-Yeon
author_sort Hwang, Sun-Young
collection PubMed
description RIG-I is a cytosolic receptor for non-self RNA that mediates immune responses against viral infections through IFNα/β production. In an attempt to identify novel tools that modulate IFNα/β production, we used SELEX technology to screen RNA aptamers that specifically target RIG-I protein. Most of the selected RIG-I aptamers contained polyU motifs in the second half regions that played critical roles in the activation of RIG-I-mediated IFNβ production. Unlike other known ligands, RIG-I aptamer bound and activated RIG-I in a 5′-triphosphate-independent manner. The helicase and RD domain of RIG-I were used for aptamer binding, but intact RIG-I protein was required to exert aptamer-mediated signaling activation. Furthermore, replication of NDV, VSV and influenza virus in infected host cells was efficiently blocked by pre- or post-treatment with RIG-I aptamer. Based on these data, we propose that RIG-I aptamer has strong potential to be an antiviral agent that specifically boosts the RIG-I-dependent signaling cascade.
format Online
Article
Text
id pubmed-3315321
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-33153212012-03-30 5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity Hwang, Sun-Young Sun, Hwa-Young Lee, Kwang-Hoon Oh, Byung-Ha Cha, Yu Jin Kim, Byeang Hyean Yoo, Joo-Yeon Nucleic Acids Res RNA RIG-I is a cytosolic receptor for non-self RNA that mediates immune responses against viral infections through IFNα/β production. In an attempt to identify novel tools that modulate IFNα/β production, we used SELEX technology to screen RNA aptamers that specifically target RIG-I protein. Most of the selected RIG-I aptamers contained polyU motifs in the second half regions that played critical roles in the activation of RIG-I-mediated IFNβ production. Unlike other known ligands, RIG-I aptamer bound and activated RIG-I in a 5′-triphosphate-independent manner. The helicase and RD domain of RIG-I were used for aptamer binding, but intact RIG-I protein was required to exert aptamer-mediated signaling activation. Furthermore, replication of NDV, VSV and influenza virus in infected host cells was efficiently blocked by pre- or post-treatment with RIG-I aptamer. Based on these data, we propose that RIG-I aptamer has strong potential to be an antiviral agent that specifically boosts the RIG-I-dependent signaling cascade. Oxford University Press 2012-03 2011-11-29 /pmc/articles/PMC3315321/ /pubmed/22127865 http://dx.doi.org/10.1093/nar/gkr1098 Text en © The Author(s) 2011. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle RNA
Hwang, Sun-Young
Sun, Hwa-Young
Lee, Kwang-Hoon
Oh, Byung-Ha
Cha, Yu Jin
Kim, Byeang Hyean
Yoo, Joo-Yeon
5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity
title 5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity
title_full 5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity
title_fullStr 5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity
title_full_unstemmed 5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity
title_short 5′-Triphosphate-RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity
title_sort 5′-triphosphate-rna-independent activation of rig-i via rna aptamer with enhanced antiviral activity
topic RNA
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315321/
https://www.ncbi.nlm.nih.gov/pubmed/22127865
http://dx.doi.org/10.1093/nar/gkr1098
work_keys_str_mv AT hwangsunyoung 5triphosphaternaindependentactivationofrigiviarnaaptamerwithenhancedantiviralactivity
AT sunhwayoung 5triphosphaternaindependentactivationofrigiviarnaaptamerwithenhancedantiviralactivity
AT leekwanghoon 5triphosphaternaindependentactivationofrigiviarnaaptamerwithenhancedantiviralactivity
AT ohbyungha 5triphosphaternaindependentactivationofrigiviarnaaptamerwithenhancedantiviralactivity
AT chayujin 5triphosphaternaindependentactivationofrigiviarnaaptamerwithenhancedantiviralactivity
AT kimbyeanghyean 5triphosphaternaindependentactivationofrigiviarnaaptamerwithenhancedantiviralactivity
AT yoojooyeon 5triphosphaternaindependentactivationofrigiviarnaaptamerwithenhancedantiviralactivity